What are the consequences of not following GDP guidelines?

Failure to follow GDP guidelines can result in the contamination, damage or tampering of medicinal products. This can lead to serious health risks to patients, financial losses for the pharmaceutical industry, and loss of public trust in the safety and efficacy of medicinal products.